These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6593

  • 1. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
    Weiden PL, Storb R, Slichter S, Warren RP, Sale GE.
    J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
    [Abstract] [Full Text] [Related]

  • 2. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R, Floersheim GL, Weiden PL, Graham TC, Kolb HJ, Lerner KG, Schroeder ML, Thomas ED.
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract] [Full Text] [Related]

  • 3. Use of antithymocyte serum in clinical and experimental marrow transplantation.
    Storb R, Weiden PL, Thomas ED.
    Postgrad Med J; 1976 Apr; 52(5 Suppl):96-103. PubMed ID: 11456
    [Abstract] [Full Text] [Related]

  • 4. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I, Raff RF, Flowers M, Niederwieser D, Graham T, Shulman H, Appelbaum FR, Schuening F, Storb R.
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [Abstract] [Full Text] [Related]

  • 5. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF, Sandmaier BM, Graham T, Loughran TP, Pettinger M, Storb R.
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [Abstract] [Full Text] [Related]

  • 6. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Aug; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 7. Effect of time on sensitization to hemophoietic grafts by preceding blood transfusion.
    Weiden PL, Storb R, Kolb HJ, Graham TC, Kao G, Thomas ED.
    Transplantation; 1975 Mar; 19(3):240-4. PubMed ID: 1094638
    [Abstract] [Full Text] [Related]

  • 8. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J, Herber M, Schwamberger S, Panzer W, Adler H, Kolb HJ.
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
    Tsoi MS, Storb R, Weiden PL, Graham TC, Schroeder ML, Thomas ED.
    J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of anti-donor serum (ADS) and donor cells on renal allograft survival in DL-A tissue-typed littermate beagles.
    Jeekel J, Obertop H, Vriesendorp HM, McDicken I, Westbroek DL.
    Transplant Proc; 1975 Sep; 7(3):435-8. PubMed ID: 1099744
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.
    Weiden PL, Storb R, Tsoi MS, Graham TC, Lerner KG, Thomas ED.
    J Immunol; 1976 May; 116(5):1212-9. PubMed ID: 774975
    [Abstract] [Full Text] [Related]

  • 15. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ, Emeson EE, Veith FJ.
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [Abstract] [Full Text] [Related]

  • 16. Treatment of canine malignancies by 1200 R total body irradiation and autologous marrow grafts.
    Weiden PL, Storb R, Lerner KG, Kao GF, Graham TC, Thomas ED.
    Exp Hematol; 1975 Apr; 3(2):124-34. PubMed ID: 1095380
    [Abstract] [Full Text] [Related]

  • 17. Tolerance induction in a large-animal model using total lymphoid irradiation and intrathymic bone marrow.
    Horton PJ, Hawthorne WJ, Walters S, Patel T, Stewart GJ, Allen RD, Chapman JR.
    Transplantation; 2008 Dec 27; 86(12):1830-6. PubMed ID: 19104430
    [Abstract] [Full Text] [Related]

  • 18. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E, Or R, Naparstek E, Zeira E, Slavin S.
    Bone Marrow Transplant; 1988 Mar 27; 3(2):129-40. PubMed ID: 3048477
    [Abstract] [Full Text] [Related]

  • 19. Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
    Ladiges WC, Storb R, Raff RF, Appelbaum FR, Sandmaier B, Schuening F, Graham T.
    Bone Marrow Transplant; 1990 Jan 27; 5(1):43-6. PubMed ID: 2297589
    [Abstract] [Full Text] [Related]

  • 20. Splenectomy does not enhance engraftment of DLA-nonidentical marrow transplants.
    Raff RF, Loughran TP, Graham T, Pepe M, Johnston B, Sale GE, Storb R.
    Exp Hematol; 1993 Feb 27; 21(2):385-7. PubMed ID: 8425577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.